ARID4B and prostate cancer: On the other hand, knockout of ARID4B in the PTEN-intact prostate cancer cell line DU145 only moderately suppressed tumor growth and cell proliferation, and not to the same extent as in PC3 cells (Supplementary Fig. 6).